Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.48 (-10.79%) Jun 5
At Loss
P/B:
1.24
Market Cap:
€ 82.08M ($ 89.39M)
Enterprise V:
€ 5.24M ($ 5.71M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Relmada Therapeutics Inc Valuation Measures